Table 7.
IGF-1
|
Gonadal stage | ||||||
|---|---|---|---|---|---|---|
| Males | 1 | 2 | 3 | 4 | 5 | Adult |
|
Reference ranges* in ng/ml |
109 to 485 |
174 to 512 |
230 to 818 |
396 776 |
402-839 |
182 to 780 |
|
Pre treatment |
|
|
|
|
|
|
| Number |
27 |
7 |
|
|
|
|
| Mean |
128 |
250 |
|
|
|
|
| SD |
64 |
81 |
|
|
|
|
| Minimum |
27 |
151 |
|
|
|
|
| Maximum |
270 |
178 |
|
|
|
|
|
Treated |
|
|
|
|
|
|
| Number |
53 |
25 |
20 |
68 |
28 |
4 |
| Mean |
190 |
415 |
496 |
548 |
575 |
321 |
| SD |
127 |
130 |
162 |
165 |
184 |
22 |
| Minimum |
64 |
200 |
122 |
224 |
269 |
292 |
| Maximum |
625 |
637 |
777 |
961 |
897 |
338 |
|
Post treatment |
|
|
|
|
|
|
| Number |
|
|
|
1 |
2 |
16 |
| Mean |
|
|
|
374 |
286 |
321 |
| SD |
|
|
|
|
57 |
101 |
| Minimum |
|
|
|
|
245 |
178 |
| Maximum |
|
|
|
|
326 |
520 |
|
Females |
Breast stage |
|||||
|
Reference ranges in ng/ml |
128 to 470 |
186 to 695 |
292 to 883 |
394 920 |
308-1138 |
182 to 780 |
|
Pre treatment |
1 |
2 |
3 |
4 |
5 |
Adult |
| Number |
9 |
3 |
|
|
|
|
| Mean |
167 |
243 |
|
|
|
|
| SD |
80 |
32 |
|
|
|
|
| Minimum |
95 |
214 |
|
|
|
|
| Maximum |
331 |
277 |
|
|
|
|
|
Treated |
|
|
|
|
|
|
| Number |
6 |
10 |
13 |
7 |
3 |
|
| Mean |
287 |
327 |
510 |
662 |
336 |
|
| SD |
95 |
98 |
192 |
222 |
63 |
|
| Minimum |
146 |
194 |
207 |
352 |
284 |
|
| Maximum |
397 |
470 |
959 |
916 |
406 |
|
|
Post treatment |
|
|
|
|
|
|
| Number |
|
|
|
2 |
5 |
5 |
| Mean |
|
|
|
440 |
244 |
300 |
| SD |
|
|
|
233 |
52 |
130 |
| Minimum |
|
|
|
276 |
192 |
164 |
| Maximum | 605 | 311 | 511 | |||
*Reference ranges from Quest Diagnostics, Pediatric Endocrinology. Ed. Delbert A. Fisher; 2001.